The Innovation Gap: The Broader Impact of Metabolic Drugs on Related Diseases

Moderators

Patrick Ellinor, MD, PhD

Acting Chief of Cardiology, Massachusetts General Hospital;

Professor of Medicine, Harvard Medical School

Jason Zemansky, PhD

SMid-Cap Biotech Analyst, BofA Global Research

Panelists

Craig Basson, MD, PhD

Chief Medical Officer, Bitterroot Bio

Joshua Cohen

Co-CEO, Amylyx Pharmaceuticals

Punit Dhillon

CEO, Skye Bioscience

Justin Klee

Co-CEO, Amylyx Pharmaceuticals

Rohan Palekar

CEO, 89bio